Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells

BMB Reports

Volumn 43, Issue 2, 2010, Pages 91-96

  Park, Yun Jung ^a   Lee, Hansoo ^a   Lee, Jeong Hyung ^a  

^a Kangwon National University   (South Korea)

Author keywords

ErbB family receptors; Invasion; MIC 1 GDF 15; Src; Transactivation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 15; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KINASE P60; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST TUMOR; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS;

EID: 77952477287     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.2.091     Document Type: Article

References (35)

1. Strelau, J., Bottner, M., Lingor, P., Suter-Crazzolara, C., Galter, D., Jaszai, J., Sullivan, A., Schober, A., Krieglstein, K. and Unsicker, K. (2000) GDF-15/MIC-1 a novel member of the TGF-β superfamily. J. Neural. Transm. Suppl. 60, 273-276.
2. Bootcov, M.R., Bauskin, A.R., Valenzuela, S.M., Moore, A.G., Bansal, M., He, X.Y., Zhang, H.P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B.J., Nicholson, R.C., Fairlie, W.D., Por, S.B., Robbins, J.M. and Breit, S.N. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. U.S.A. 94, 11514-11519.
3. Bauskin, A.R., Brown, D.A., Kuffner, T., Johnen, H., Luo, X.W., Hunter, M. and Breit, S.N. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 66, 4983-4986.
4. Paralkar, V.M., Vail, A.L., Grasser, W.A., Brown, T.A., Xu, H., Vukicevic, S., Ke, H.Z., Qi, H., Owen, T.A. and Thompson, D.D. (1998) Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J. Biol. Chem. 273, 13760-13767.
5. Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y. and Lu, L. (1997) PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta. 1354, 40-44.
6. Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J.D., Niessen, H.W., Drexler, H. and Wollert, K.C. (2006) The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ. Res. 98, 351-360.
7. Welsh, J.B., Sapinoso, L.M., Su, A.I., Kern, S.G., Wang-Rodriguez, J., Moskaluk, C.A., Frierson, H.F. Jr. and Hampton, G.M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.
8. Buckhaults, P., Rago, C., St. Croix, B., Romans, K.E., Saha, S., Zhang, L., Vogelstein, B. and Kinzler, K.W. (2001) Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61, 6996-7001.
9. Welsh, J.B., Sapinoso, L.M., Kern, S.G., Brown, D.A., Liu, T., Bauskin, A.R., Ward, R.L., Hawkins, N.J., Quinn, D.I., Russell, P.J., Sutherland, R.L., Breit, S.N., Moskaluk, C.A., Frierson, H.F. and Hampton, G.M. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U.S.A. 100, 3410-3415.
10. Brown, D.A., Ward, R.L., Buckhaults, P., Liu, T., Romans, K.E., Hawkins, N.J., Bauskin, A.R., Kinzler, K.W., Vogelstein, B. and Breit, S.N. (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642-2650.
11. Koopmann, J., Buckhaults, P., Brown, D.A., Zahurak, M.L., Sato, N., Fukushima, N., Sokoll, L.J., Chan, D.W., Yeo, C. J, Hruban, R.H., Breit, S.N., Kinzler, K.W., Vogelstein, B. and Goggins, M. (2004) Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin. Cancer Res. 10, 2386-2392.
12. Li, P.X., Wong, J., Ayed, A,. Ngo, D., Brade, A.M., Arrowsmith, C., Austin, R.C. and Klamut, H.J. (2000) Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 75, 20127-20135.
13. Tan, M., Wang, Y., Guan, K. and Sun, Y. (2000) PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 109-114.
14. Graichen, R., Liu, D., Sun, Y., Lee, K.O. and Lobie, P.E. (2002) Autocrine human growth hormone inhibits placental transforming growth factor-β gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J. Biol. Chem. 277, 26662-26672.
15. Albertoni, M., Shaw, P.H., Nozaki, M., Godard, S., Tenan, M., Hamou, M.F., Fairlie, D.W., Breit, S.N., Paralkar, V.M., de Tribolet, N., Van Meir, E.G. and Hegi, M.E. (2002) Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21, 4212-4219.
16. Lee, D.H., Yang, Y., Lee, S.J., Kim, K.Y., Koo, T.H., Shin, S.M., Song, K.S., Lee, Y.H., Kim, Y.J., Lee, J.J., Choi, I. and Lee, J.H. (2003) Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63, 4648-4655.
17. Kim, K.K., Lee, J.J., Yang, Y., You, K.H., and Lee, J.H. (2008) Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 19, 704-712.
18. Boyle, G.M., Pedley, J., Martyn, A.C., Banducci, K.J., Strutton, G. M, Brown, D.A., Breit, S.N. and Parsons, P.G. (2009) Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity. J. Invest. Dermatol. 129, 383-391.
19. Johnen, H., Lin, S., Kuffner, T., Brown, D.A., Tsai, V.W., Bauskin, A.R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., Hunter, M., Fairlie, W.D., Lee, N.J., Enriquez, R.F., Baldock, P.A., Corey, E., Apple,F. S, Murakami, M. M, Lin, E.J., Wang, C., During, M.J., Sainsbury, A., Herzog, H. and Breit, S.N. (2007) Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1. Nat. Med. 13, 1333-1340.
20. Olayioye, M.A., Neve, R.M., Lane, H.A. and Hynes, N.E. (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167.
21. Yarden, Y. and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137.
22. Zwick, E., Hackel, P. O., Prenzel, N. and Ullrich, A. (1999) The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20, 408-412.
23. Argast, G. M., Campbell, J. S., Brooling, J. T. and Fausto, N. (2004) Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279, 34530-34536.
24. Qiu, Y., Ravi, L. and Kung, H. J. (1998) Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393, 83-85.
25. Cabioglu, N., Summy, J., Miller, C., Parikh, N. U., Sahin, A. A., Tuzlali, S., Pumiglia, K., Gallick, G. E., and Price, J. E. (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 65, 6493-6497.
26. Fischer, O. M., Hart, S., Gschwind, A. and Ullrich, A. (2003) EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31, 1203-1208.
27. Tice, D. A., Biscardi, J. S., Nickles, A. L., and Parsons, S. J. (1999) Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 1415-1420.
28. Ishizawar, R. C., Miyake, T. and Parsons, S. J. (2007) c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 26, 3503-3510.
29. Xu, W., Yuan, X., Beebe, K., Xiang, Z. and Neckers, L. (2007) Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity. Mol. Cell. Biol. 27, 220-228.
30. Biscardi, J. S., Maa, M. C., Tice, D. A., Cox, M. E., Leu, T. H. and Parsons, S. J. (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343.
31. Mook, O. R., Frederiks, W. M. and Van Noorden, C. J. (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta. 1705, 69-89.
32. Wu, Z. S., Wu, Q., Yang, J. H., Wang, H. Q., Ding, X. D., Yang, F. and Xu, X. C. (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int. J. Cancer. 122, 2050-2056.
33. Kim, S., Choi, J. H., Lim, H. I., Lee, S. K., Kim, W. W., Cho, S., Kim, J. S., Kim, J. H., Choe, J. H., Nam, S. J., Lee, J. E. and Yang, J. H. (2009) EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21, 892-898.
34. Yao, J., Xiong, S., Klos, K., Nguyen, N., Grijalva, R., Li, P., and Yu, D. (2001) Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells. Oncogene 20, 8066-8074.
35. Cho, H. J. and Nam, K. S. (2007) Inhibitory effect of gink-golide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9. J. Biochem. Mol. Biol. 40, 678-683.